Literature DB >> 19273222

Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.

Jaap Mulder1, Saul J Karpen, Uwe J F Tietge, Folkert Kuipers.   

Abstract

Inflammation-induced cholestasis (IIC) is a frequently occurring phenomenon. A central role in its pathogenesis is played by nuclear receptors (NRs). These ligand-activated transcription factors not only regulate basal expression of hepatobiliary transport systems, but also mediate adaptive responses to inflammation and possess anti-inflammatory characteristics. The latter two functions may be exploited in the search for new treatments for IIC as well as for cholestasis in general. Current knowledge of the pathogenesis of IIC and the dual role NRs in this process are reviewed. Special interest is given to the use of NRs as potential targets for intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273222      PMCID: PMC4085779          DOI: 10.2741/3400

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  277 in total

Review 1.  The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.

Authors:  Karolien De Bosscher; Wim Vanden Berghe; Guy Haegeman
Journal:  Endocr Rev       Date:  2003-08       Impact factor: 19.871

2.  Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli.

Authors:  Liming Pei; Antonio Castrillo; Mingyi Chen; Alexander Hoffmann; Peter Tontonoz
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

3.  An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

Authors:  W Xie; A Radominska-Pandya; Y Shi; C M Simon; M C Nelson; E S Ong; D J Waxman; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.

Authors:  B A Janowski; P J Willy; T R Devi; J R Falck; D J Mangelsdorf
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

5.  Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.

Authors:  Antonio Moschetta; Angie L Bookout; David J Mangelsdorf
Journal:  Nat Med       Date:  2004-11-21       Impact factor: 53.440

6.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

Authors:  T T Lu; M Makishima; J J Repa; K Schoonjans; T A Kerr; J Auwerx; D J Mangelsdorf
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

7.  Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice.

Authors:  Jaspreet S Gujral; Jie Liu; Anwar Farhood; Jack A Hinson; Hartmut Jaeschke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-10-16       Impact factor: 4.052

8.  Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.

Authors:  Takeshi Inagaki; Antonio Moschetta; Youn-Kyoung Lee; Li Peng; Guixiang Zhao; Michael Downes; Ruth T Yu; John M Shelton; James A Richardson; Joyce J Repa; David J Mangelsdorf; Steven A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

Review 9.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

10.  Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation.

Authors:  Romi Ghose; Tracy L Zimmerman; Sundararajah Thevananther; Saul J Karpen
Journal:  Nucl Recept       Date:  2004-08-16
View more
  9 in total

Review 1.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

Review 2.  Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.

Authors:  M Arrese; S J Karpen
Journal:  Clin Pharmacol Ther       Date:  2010-03-03       Impact factor: 6.875

Review 3.  Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.

Authors:  Douglas G Burrin; Ken Ng; Barbara Stoll; Miguel Sáenz De Pipaón
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

4.  Differential regulation of hepatic organic cation transporter 1, organic anion-transporting polypeptide 1a4, bile-salt export pump, and multidrug resistance-associated protein 2 transporter expression in lymphocyte-deficient mice associates with interleukin-6 production.

Authors:  Connor E Bodeman; Anika L Dzierlenga; Catherine M Tally; Ryan M Mulligan; April D Lake; Nathan J Cherrington; Susan C McKarns
Journal:  J Pharmacol Exp Ther       Date:  2013-08-08       Impact factor: 4.030

5.  Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells.

Authors:  Rebecca Schneider Aguirre; Saul J Karpen
Journal:  Mol Pharmacol       Date:  2013-05-20       Impact factor: 4.436

6.  Chicken bile powder protects against α-naphthylisothiocyanate-induced cholestatic liver injury in mice.

Authors:  Yi-Fei Li; Jia-Sheng Wu; Yuan-Yuan Li; Yan Dai; Min Zheng; Jia-Kai Zeng; Guo-Feng Wang; Tian-Ming Wang; Wen-Kai Li; Xue-Yan Zhang; Ming Gu; Cheng Huang; Li Yang; Zheng-Tao Wang; Yue-Ming Ma
Journal:  Oncotarget       Date:  2017-09-27

7.  Inflammation-induced cholestasis in cancer cachexia.

Authors:  Morgane M Thibaut; Martina Sboarina; Martin Roumain; Sarah A Pötgens; Audrey M Neyrinck; Florence Destrée; Justine Gillard; Isabelle A Leclercq; Guillaume Dachy; Jean-Baptiste Demoulin; Anne Tailleux; Sophie Lestavel; Marialetizia Rastelli; Amandine Everard; Patrice D Cani; Paolo E Porporato; Audrey Loumaye; Jean-Paul Thissen; Giulio G Muccioli; Nathalie M Delzenne; Laure B Bindels
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-12-22       Impact factor: 12.910

Review 8.  Cachexia, a Systemic Disease beyond Muscle Atrophy.

Authors:  Elisabeth Wyart; Laure B Bindels; Erica Mina; Alessio Menga; Serena Stanga; Paolo E Porporato
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

9.  Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice.

Authors:  Morgane M Thibaut; Justine Gillard; Adeline Dolly; Martin Roumain; Isabelle A Leclercq; Nathalie M Delzenne; Giulio G Muccioli; Laure B Bindels
Journal:  Cancers (Basel)       Date:  2021-12-20       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.